![साप्ताहिक राशिफल (01 जुलाई से 07 जुलाई 2024)](https://i-invdn-com.investing.com/news/World_News_8_150x108_S_1420026210.jpg)
कृपया अन्य खोज का प्रयास करें
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 commercial products and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, immunology, respiratory, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
David C. Hodgson | 67 | 2022 | Independent Director |
Pablo Gerardo Legorreta | 59 | 1996 | Founder, Chairman of the Board & CEO |
Henry A. Fernandez | 66 | 2020 | Lead Independent Director |
Gregory Norden | 66 | 2020 | Independent Director |
Ted W. Love | 65 | 2020 | Independent Director |
Bonnie L. Bassler | 62 | 2020 | Independent Director |
Catherine M. Engelbert | 59 | 2020 | Independent Director |
Errol B. De Souza | 71 | 2020 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है